The predictable engineering of genetic circuits is fundamentally challenged by compositional context-dependence, where a device's function is altered by its interconnected parts and host cellular environment.
This article provides a comprehensive guide for researchers and drug development professionals on establishing robust performance benchmarking for engineered microbial strains.
This article provides a comprehensive analysis of the integration of Life Cycle Assessment (LCA) with metabolic engineering strategies to develop environmentally sustainable bioprocesses.
This article provides a comprehensive overview of the strategies, methodologies, and real-world applications for validating artificial intelligence (AI)-predicted targets in metabolic engineering.
This article provides a comprehensive performance analysis of the two predominant microbial workhorses in biotechnology: Escherichia coli and Saccharomyces cerevisiae.
This article provides a comprehensive guide for researchers and drug development professionals tackling the critical challenge of oxygen transfer in high-density cell cultures.
This article provides a comprehensive analysis of contemporary strategies for enhancing cofactor regeneration in biosynthetic pathways, a critical determinant of economic viability for producing pharmaceuticals and value-added chemicals.
This article provides a comprehensive analysis of contemporary strategies for enhancing enzyme thermostability, a critical factor for efficiency and cost-effectiveness in industrial and pharmaceutical processes.
This article provides a comprehensive overview of modern strategies for managing toxic intermediates across drug development and chemical safety assessment.
Engineered microbial systems often face significant challenges due to metabolic burden, which can impair cell growth, reduce genetic stability, and diminish the production titers of valuable biochemicals and therapeutics.